Showing 3411-3420 of 20917 results for "".
- Researchers Review Findings and Clinical Messages from the Women’s Health Initiative 30 Years After Launchhttps://reachmd.com/news/researchers-review-findings-and-clinical-messages-from-the-womens-health-initiative-30-years-after-launch/2463095/Data from influential study underscore the importance of personalized and shared decision-making to support the health of postmenopausal womenWHAT: A new review in
- Global Life Expectancy to Increase by Nearly 5 Years by 2050 Despite Geopolitical, Metabolic, and Environmental Threats, Reports New Global Studyhttps://reachmd.com/news/global-life-expectancy-to-increase-by-nearly-5-years-by-2050-despite-geopolitical-metabolic-and-environmental-threats-reports-new-global-study/2463101/View infographicThe latest findings from the Global Burden of Disease Study (GBD) 2021,
- Allen Institute for Immunology and Seattle Children's Research Institute Launch Study to Unravel Molecular Mysteries of Pediatric IBDhttps://reachmd.com/news/allen-institute-for-immunology-and-seattle-childrens-research-institute-launch-study-to-unravel-molecular-mysteries-of-pediatric-ibd/2463077/New clinical trial provides hope for children with Inflammatory bowel disease (IBD) SEATTLE, May 13, 2024 /PRNewswire/ -- With pediatric inflammatory bowel disease (IBD) diagnoses
- Review Unveils Cell-Based Sepsis Immunotherapies in Chinahttps://reachmd.com/news/review-unveils-cell-based-sepsis-immunotherapies-in-china/2463074/Imagine the human body mounting an excessively heightened reaction to an infection, causing multiple organ failures and posing a risk of death. This condition, recognized as sepsis, affects approximately 49 million individuals worldwide annually. To thus reduce the mortality rate a
- New Cardiac Research Will Save Women’s Lives by Improving Detection of Heart Failurehttps://reachmd.com/news/new-cardiac-research-will-save-womens-lives-by-improving-detection-of-heart-failure/2463058/Peer-reviewed – Observational Study - People An important new study has advanced how heart failure is detected in women – meaning more female patients can be diagnosed and at an earlier stage. Researchers led by teams
- Innovative USask 'Mini-Brains' Could Revolutionize Alzheimer’s Treatmenthttps://reachmd.com/news/innovative-usask-mini-brains-could-revolutionize-alzheimers-treatment/2463047/In testing, Wenzel's "mini-brains" more accurately reflect a fully-fledged adult human brain, so they can be used to more closely examine neurological conditions of adult patients, such as Alzheimer disease. And for those “mini-brains” created from the stem cells of individuals who have A
- New Research Reveals Urgent Need for Integrated Care in Pediatric Epilepsyhttps://reachmd.com/news/new-research-reveals-urgent-need-for-integrated-care-in-pediatric-epilepsy/2463041/Credit: Pixabay/CC0 Public Domain Findings from the Kennedy Krieger Institute emphasize the critical importance of in
- Potential Power and Pitfalls of Harnessing Artificial Intelligence for Sleep Medicinehttps://reachmd.com/news/potential-power-and-pitfalls-of-harnessing-artificial-intelligence-for-sleep-medicine/2463040/In a new research commentary, the Artificial Intelligence in Sleep Medicine Committee of the American Academy of Sleep Medicine highlights how artificial intelligence stands on the threshold of making monumental contributions to the field of sleep medicine. Through a strategic analysis, the
- Participants of Pioneering CRISPR Gene Editing Trial See Vision Improvehttps://reachmd.com/news/participants-of-pioneering-crispr-gene-editing-trial-see-vision-improve/2463010/In early 2020, surgeons at the OHSU Casey Eye Institute performed the first in-body CRISPR gene editing procedure as part of the Phase 1/2 BRILLIANCE clinical trial. Now, new trial results show about 79% of the 14 trial’s participants with a rare form of inherited blindness
- Phase 2b/3 Trial of Izokibep Meets Primary Endpoints for Psoriatic Arthritis, According to Positive Top-Line Resultshttps://reachmd.com/news/phase-2b3-trial-of-izokibep-meets-primary-endpoints-for-psoriatic-arthritis-according-to-positive-top-line-results/2463016/In a recent news release,1 Acelyrin, Inc.